Symbol="KDNY"
AssetType="Common Stock"
Name="Chinook Therapeutics Inc"
Description="Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision drugs for kidney disease. The company is headquartered in Seattle, Washington."
CIK="1435049"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="740 HEINZ AVENUE, BERKELEY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2626592000"
EBITDA="-197027008"
PERatio="None"
PEGRatio="None"
BookValue="6.17"
DividendPerShare="0"
DividendYield="0"
EPS="-3.28"
RevenuePerShareTTM="0.078"
ProfitMargin="0"
OperatingMarginTTM="-38.44"
ReturnOnAssetsTTM="-0.235"
ReturnOnEquityTTM="-0.516"
RevenueTTM="5259000"
GrossProfitTTM="-135083000"
DilutedEPSTTM="-3.28"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.322"
AnalystTargetPrice="39.3"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="27.9"
PriceToBookRatio="3.057"
EVToRevenue="19.67"
EVToEBITDA="-11.5"
Beta="0.683"
num_52WeekHigh="39.44"
num_52WeekLow="17.72"
num_50DayMovingAverage="28.76"
num_200DayMovingAverage="24.17"
SharesOutstanding="67039000"
DividendDate="2020-10-02"
ExDividendDate="None"
symbol="KDNY"
open="39.16"
high="39.20"
low="39.08"
price="39.11"
volume="671443.00"
latest_trading_day="2023-07-12"
previous_close="39.08"
change="0.03"
change_percent="0.0768%"
aroon_positive_momentum_days="37"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Trending Low"
value_analysis="Bearish Trend"
Aroon_change="FALSE"
Aroon_momentum="37"
Volume_recent_avg="1120145"
Change_recent_avg="0.01"
Delta_recent_avg="0.9"
Variance_recent_avg="0.45"
Change_ratio_recent_avg="0.01"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="37"
Aroon_momentum_negative="63"
image_negative_thumbnail_id_1="1137"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0170.jpeg"
image_negative_thumbnail_id_2="126"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0050.jpeg"
image_neutral_thumbnail_id_1="568"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0031.jpeg"
image_neutral_thumbnail_id_2="549"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_positive_thumbnail_id_1="659"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0049.jpeg"
image_positive_thumbnail_id_2="984"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0146.jpeg"
image_professor_thumbnail_id_1="1200"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
